Display options
Cite
Mylroie AA, Tucker C, Rosselli-Austin L. Lead-exposure of neonatal rats through maternal milk : A confounded model. Biol Trace Elem Res. 1987;14(3):209-16doi: 10.1007/BF02795687.
Mylroie, A. A., Tucker, C., & Rosselli-Austin, L. (1987). Lead-exposure of neonatal rats through maternal milk : A confounded model. Biological trace element research, 14(3), 209-16. https://doi.org/10.1007/BF02795687
Mylroie, A A, et al. "Lead-exposure of neonatal rats through maternal milk : A confounded model." Biological trace element research vol. 14,3 (1987): 209-16. doi: https://doi.org/10.1007/BF02795687
Mylroie AA, Tucker C, Rosselli-Austin L. Lead-exposure of neonatal rats through maternal milk : A confounded model. Biol Trace Elem Res. 1987 Dec;14(3):209-16. doi: 10.1007/BF02795687. PMID: 24254822.
Copy Download .nbib Format: NLM
Share it on

Biol Trace Elem Res. 1987 Dec;14(3):209-16. doi: 10.1007/BF02795687.

Lead-exposure of neonatal rats through maternal milk : A confounded model.

Biological trace element research

A A Mylroie, C Tucker, L Rosselli-Austin

Affiliations

  1. Department of Physical Sciences, Chicago State University, 60628, Chicago, IL.

PMID: 24254822 DOI: 10.1007/BF02795687

Abstract

Lead-exposed neonatal rats are frequently used as a model for plumbism in children. In most studies,PPb is administered to the dam, and it is assumed that the pups are exposed to Pb primarily from the dam's milk. Rat pups, however, are coprophagic and begin to consume the maternal feces in their second postnatal week. This experiment was designed to determine whether the maternal feces are a significant source of Pb in pups exposed via the lactating dam. Dams were administered Pb as lead acetate (PbAc), either through their drinking water (500 ppm PbAc) or through twice daily intubations (3 mg PbAc/Kg body wt) from postpartum d 1 (P1) to P21 (P0=day of birth). Control dams were administered deionized water. The dams were housed with their litters in stainless-steel hanging cages with wire-screened bottoms. Litters of exposed and control dams treated through their drinking water had access to either Pb-containing or Pb-free maternal fecal matter for 2 h/d during the late lactation period. Half of the litters from intubated dams had continuous access to maternal feces throughout the lactation period, whereas access was curtailed at P14 in the other litters. Lead content of the feces from Pb-exposed dams ranged from 1000 to 5000 μg Pb/g wet wt. At P21, Pb concentrations were 2-4 times higher in blood, brain, bone, and liver of pups that had access to Pb-contaminated feces than in pups that were exposed to Pb primarily through the mother's milk. When estimating exposure levels in pups receiving Pb through the lactating dam, coprophagy and the high content of Pb in the dam's feces must be taken into consideration.

References

  1. Exp Neurol. 1984 Sep;85(3):620-30 - PubMed
  2. Toxicol Appl Pharmacol. 1975 Jun;32(3):628-37 - PubMed
  3. J Neuropathol Exp Neurol. 1974 Oct;33(5):671-86 - PubMed
  4. J Nutr. 1957 Dec 10;63(4):489-98 - PubMed
  5. J Nutr. 1972 May;102(5):647-52 - PubMed
  6. Toxicol Appl Pharmacol. 1977 Aug;41(2):361-7 - PubMed
  7. Environ Health Perspect. 1975 Dec;12:119-23 - PubMed
  8. Science. 1975 Jan 31;187(4174):359-61 - PubMed
  9. Experientia. 1983 Sep 15;39(9):1030-1 - PubMed
  10. Pharmacol Biochem Behav. 1982 Apr;16(4):631-5 - PubMed
  11. Neurotoxicology. 1981 Dec;2(4):725-42 - PubMed
  12. J Toxicol Environ Health. 1982 Jan;9(1):77-86 - PubMed
  13. Physiol Behav. 1981 Feb;26(2):301-6 - PubMed
  14. Neurobiol Aging. 1984 Winter;5(4):297-307 - PubMed
  15. Acta Neuropathol. 1966 Jun 1;6(3):266-78 - PubMed
  16. Toxicol Appl Pharmacol. 1974 Apr;28(1):88-96 - PubMed
  17. Neurobehav Toxicol Teratol. 1983 Sep-Oct;5(5):527-31 - PubMed
  18. Toxicol Lett. 1981 Feb;7(4-5):373-8 - PubMed
  19. Neurochem Res. 1984 Dec;9(12):1675-88 - PubMed
  20. Environ Res. 1982 Jun;28(1):147-53 - PubMed
  21. Nature. 1971 Oct 22;233(5321):564 - PubMed
  22. J Toxicol Environ Health. 1979 Jul;5(4):671-82 - PubMed
  23. Pharmacol Biochem Behav. 1979 Aug;11(2):165-71 - PubMed
  24. Neuropharmacology. 1986 Feb;25(2):151-60 - PubMed
  25. Toxicol Appl Pharmacol. 1977 Jun;40(3):577-87 - PubMed
  26. Toxicol Appl Pharmacol. 1973 Dec;26(4):539-48 - PubMed
  27. Toxicol Appl Pharmacol. 1979 Dec;51(3):447-54 - PubMed
  28. Toxicol Appl Pharmacol. 1978 Feb;43(2):351-60 - PubMed
  29. Am J Ment Defic. 1974 Jul;79(1):5-9 - PubMed
  30. Neuropathol Appl Neurobiol. 1983 Mar-Apr;9(2):87-108 - PubMed
  31. Brain Res. 1978 May 19;147(1):131-8 - PubMed
  32. Pharmacol Biochem Behav. 1981 Oct;15(4):641-9 - PubMed
  33. Environ Health Perspect. 1975 Dec;12:89-95 - PubMed
  34. Physiol Behav. 1983 Apr;30(4):539-43 - PubMed
  35. Environ Health Perspect. 1976 Dec;18:147-57 - PubMed
  36. Pharmacology. 1976;14(5):435-42 - PubMed
  37. Science. 1973 Dec 7;182(4116):1022-4 - PubMed
  38. Physiol Behav. 1983 Apr;30(4):583-9 - PubMed
  39. J Neuropathol Exp Neurol. 1977 Jan;36(1):169-93 - PubMed

Publication Types